Historical archive

Coronavirus – How much social distance?

Keep your distance to help slow down COVID-19

Extended interval between first and second vaccine dose to vaccinate more people faster

The Ministry of Health and Care Services has decided to extend the interval between the first and second dose of mRNA vaccines against COVID-19 after advice from the NIPH.

What can vaccinated people do now?

We have increasingly reliable knowledge that coronavirus vaccines give good protection against becoming ill and from infecting others. We can use that knowledge to ease measures where possible.

When should sick children stay home from childcare or primary school?

Norwegian Institute of Public Health's recommendation  about AstraZeneca vaccine

The Norwegian Institute of Public Health has recommended stopping further use of the AstraZeneca vaccine (Vaxzevria) in the Coronavirus Immunisation Programme in Norway.

Information about your coronavirus test

Information letter to people who have had a coronavirus test, available in several languages.

Extended pause for AstraZeneca vaccine

The Norwegian Institute of Public Health has decided to extend the pause in the use of the AstraZeneca vaccine because further investigations are necessary.

See signs of protection against COVID-19 among those vaccinated

During the last five weeks, a sharp increase in transmission has been seen among most age groups in Norway, but not among the oldest who have the highest vaccination coverage.

UK virus variant associated with higher risk of hospital admission

The UK variant of the coronavirus is associated with a higher risk of being admitted to hospital, even among young adults, according to a new study from the Norwegian Institute of Public Health.

AstraZeneca vaccine still on hold in Norway

The Norwegian Institute of Public Health (NIPH) will keep use of the AstraZeneca vaccine on hold in Norway and will continue a thorough review of the situation. An update will be provided at the end of week 12.

Norwegian Medicines Agency investigating notification about death

The Norwegian Medicines Agency and the Norwegian Institute of Public Health (NIPH) have received a report of a death following vaccination with the AstraZeneca vaccine.

AstraZeneca vaccine: When to consult a doctor

An overview of common side effects after AstraZeneca vaccination, and what people should be alert for, is released by the Norwegian Medicines Agency and the Norwegian Institute of Public Health.

Norwegian Medicines Agency notified of blood clots and bleeding in younger people after vaccination with AstraZeneca vaccine

The Norwegian Medicine Agency is asking people who had the AstraZeneca vaccine in the last 14 days and who feel increasingly unwell to be alert.

Norwegian Medicines Agency investigating notification about death

The Norwegian Medicines Agency and the Norwegian Institute of Public Health (NIPH) have received a report of a death following vaccination with the AstraZeneca vaccine.

Vaccination with AstraZeneca vaccine against COVID-19 put on hold

Following a report in Denmark of a death from a blood clot after receiving the AstraZeneca vaccine, Norway has chosen to suspend vaccination with the AstraZeneca vaccine.

Changes in the vaccine strategy

The Norwegian Institute of Public Health will allocate more vaccine doses to areas at particular risk for infection and introduce a new distribution key for vaccines.

AstraZeneca vaccine recommended for all over 18 years of age

The Norwegian Institute of Public Health (NIPH) now recommends giving the coronavirus vaccine from AstraZeneca to people over the age of 18.

Advice for corona research

Here you will find good advice for researchers who are planning and conducting research projects related to covid-19.

The Smittestopp app now works across national borders

Today, the Norwegian Smittestopp app was linked to other infection tracking apps in the EU and EEA.

Privacy policy - Processing of personal data

This privacy policy explains how we process personal data about you and what rights you have.